Protagonist Therapeutics (PTGX) IPO Opened Flat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. BA
3. AVGO
4. HOOD
5. SPY
6. STX
7. CDNS
8. ANT
9. RCL
10. INTC

Go back to Protagonist Therapeutics (PTGX) IPO Opened Flat

Protagonist Therapeutics Announces Pricing of Initial Public Offering

August 10, 2016 10:48 PM EDT

MILPITAS, Calif., Aug. 10, 2016 /PRNewswire/ -- Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs, today announced the pricing of its initial public offering of 7,500,000 shares of common stock, at a price to the public of $12 per share, before underwriting discounts and commissions. The shares are expected to begin trading on The NASDAQ Global Market on August 11, 2016, under the symbol "PTGX." In addition,... More